Literature DB >> 11496122

Differential nociceptive responses in mice lacking the alpha(1B) subunit of N-type Ca(2+) channels.

S Hatakeyama1, M Wakamori, M Ino, N Miyamoto, E Takahashi, T Yoshinaga, K Sawada, K Imoto, I Tanaka, T Yoshizawa, Y Nishizawa, Y Mori, T Niidome, S Shoji.   

Abstract

The role of N-type Ca(2+) channels in nociceptive transmission was examined in genetically engineered mice lacking the alpha(1B) subunit of N-type channels and in their heterozygote and wild-type littermates. In alpha(1B)-deficient mice, N-type channel activities in dorsal root ganglion neurons and spinal synaptoneurosomes were eliminated without compensation by other types of voltage-dependent Ca(2+) channels. The alpha(1B)-deficient mice showed a diminution in the phase 2 nociceptive responses more extensively than in the phase 1 nociceptive responses of the formalin test. The alpha(1B)-deficient mice exhibited significantly increased thermal nociceptive thresholds in the hot plate test, but failed to increase mechanical nociceptive thresholds in the tail pinch test. These results suggest a crucial role of N-type channels in nociceptive transmission, especially for persistent pain like phase 2 of the formalin test and for nociception induced by thermal stimuli.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496122     DOI: 10.1097/00001756-200108080-00027

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  38 in total

Review 1.  In vivo analysis of voltage-dependent calcium channels.

Authors:  Ling Liu; Theresa A Zwingman; Colin F Fletcher
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

2.  N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Naoki Tokuhara; Kana Namiki; Mai Uesugi; Chihiro Miyamoto; Makoto Ohgoh; Katsutoshi Ido; Takashi Yoshinaga; Toshihiko Yamauchi; Junro Kuromitsu; Sadao Kimura; Norimasa Miyamoto; Yoshitoshi Kasuya
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

3.  SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.

Authors:  Lei Wen; Sheng Yang; Haifa Qiao; Zhenwei Liu; Wenxia Zhou; Yongxiang Zhang; Peitang Huang
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 4.  Neuronal calcium channels: splicing for optimal performance.

Authors:  Annette C Gray; Jesica Raingo; Diane Lipscombe
Journal:  Cell Calcium       Date:  2007-05-18       Impact factor: 6.817

Review 5.  Voltage-gated calcium channels in chronic pain: emerging role of alternative splicing.

Authors:  Leigh Anne Swayne; Emmanuel Bourinet
Journal:  Pflugers Arch       Date:  2008-04-04       Impact factor: 3.657

6.  N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice.

Authors:  J-H Duan; K E Hodgdon; C M Hingtgen; G D Nicol
Journal:  Neuroscience       Date:  2014-04-19       Impact factor: 3.590

Review 7.  Regulation of voltage-gated calcium channels by proteolysis.

Authors:  Kathryn Abele; Jian Yang
Journal:  Sheng Li Xue Bao       Date:  2012-10-25

8.  Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.

Authors:  Xian Xuan Chi; Brian S Schmutzler; Joel M Brittain; Yuying Wang; Cynthia M Hingtgen; Grant D Nicol; Rajesh Khanna
Journal:  J Cell Sci       Date:  2009-11-10       Impact factor: 5.285

9.  Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Authors:  Vinicius M Gadotti; Chris Bladen; Fang Xiong Zhang; Lina Chen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-08-19       Impact factor: 3.657

Review 10.  Targeting voltage-gated calcium channels for neuropathic pain management.

Authors:  Danielle Perret; Z David Luo
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.